[Current treatment of tuberculosis].
Tuberculosis (TB) is a growing national and international health concern today. A revision of pharmacological treatment of TB is done in this issue. Regimens for TB disease and latent TB treatment are described. Common adverse reactions and drug interactions of first and second-line antituberculosis drug are summarized in tables. Management strategies to improve treatment adherence and TB control, treat special situations like immunodeficiences, pregnancy, hepatic and renal impairment and multidrug resistant TB are presented. In a next future the prospects for using more effective and shorter new treatments to fight against this disease are not very promising.
García Ramos
R
R
Servicio de Farmacia, Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña.
Lado Lado
F L
FL
Túnez Bastida
V
V
Pérez del Molino Bernal
M L
ML
Cabarcos Ortiz de Barrón
A
A
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023801:Directly Observed Therapy; D004347:Drug Interactions; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008107:Liver Diseases / Q000150:complications; D008297:Male; D010349:Patient Compliance; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D051437:Renal Insufficiency / Q000150:complications; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents
Tratamiento actual de la tuberculosis.